BACKGROUND: In 2004 an outbreak of avian influenza of the H7N3 subtype occurred among poultry in British Columbia, Canada. We report compliance with recommended protective measures and associated human infections during this outbreak. METHODS: We sought voluntary participation by anyone (cullers, farmers and their families) involved in efforts to control the poultry outbreak. Recruitment was by advertisements at the worker deployment site, in local media and through newsletters sent directly to farmers. Sera were tested for antibody to H7N3 by microneutralization assay. A subset of 16 sera (including convalescent sera from 2 unprotected workers with conjunctivitis from whom virus had been isolated) was further tested by Western blot and routine and modified hemagglutination inhibition assays. RESULTS: A total of 167 people (20% to 25% of all workers) participated between May 7 and July 26, 2004. Of these, 19 had experienced influenza-like illness and 21 had experienced red or watery eyes. There was no significant association between illness reports and exposure to infected birds. Among 65 people who entered barns with infected birds, 55 (85%) had received influenza vaccine, 48 (74%) had received oseltamivir, and 55 (85%), 54 (83%) and 36 (55%) reported always wearing gloves, mask or goggles, respectively. Antibody to the H7 subtype was not detected in any sera. INTERPRETATION: During the BC outbreak, compliance with recommended protective measures, especially goggles, was incomplete. Multiple back-up precautions, including oseltamivir prophylaxis, may prevent human infections and should be readily accessible and consistently used by those involved in the control of future outbreaks of avian influenza in poultry. Localized human avian influenza infections may not result in serologic response despite confirmed viral detection and culture.
BACKGROUND: In 2004 an outbreak of avian influenza of the H7N3 subtype occurred among poultry in British Columbia, Canada. We report compliance with recommended protective measures and associated humaninfections during this outbreak. METHODS: We sought voluntary participation by anyone (cullers, farmers and their families) involved in efforts to control the poultry outbreak. Recruitment was by advertisements at the worker deployment site, in local media and through newsletters sent directly to farmers. Sera were tested for antibody to H7N3 by microneutralization assay. A subset of 16 sera (including convalescent sera from 2 unprotected workers with conjunctivitis from whom virus had been isolated) was further tested by Western blot and routine and modified hemagglutination inhibition assays. RESULTS: A total of 167 people (20% to 25% of all workers) participated between May 7 and July 26, 2004. Of these, 19 had experienced influenza-like illness and 21 had experienced red or watery eyes. There was no significant association between illness reports and exposure to infected birds. Among 65 people who entered barns with infected birds, 55 (85%) had received influenza vaccine, 48 (74%) had received oseltamivir, and 55 (85%), 54 (83%) and 36 (55%) reported always wearing gloves, mask or goggles, respectively. Antibody to the H7 subtype was not detected in any sera. INTERPRETATION: During the BC outbreak, compliance with recommended protective measures, especially goggles, was incomplete. Multiple back-up precautions, including oseltamivir prophylaxis, may prevent humaninfections and should be readily accessible and consistently used by those involved in the control of future outbreaks of avian influenza in poultry. Localized human avian influenza infections may not result in serologic response despite confirmed viral detection and culture.
Authors: Ron A M Fouchier; Peter M Schneeberger; Frans W Rozendaal; Jan M Broekman; Stiena A G Kemink; Vincent Munster; Thijs Kuiken; Guus F Rimmelzwaan; Martin Schutten; Gerard J J Van Doornum; Guus Koch; Arnold Bosman; Marion Koopmans; Albert D M E Osterhaus Journal: Proc Natl Acad Sci U S A Date: 2004-01-26 Impact factor: 11.205
Authors: David L Suarez; Dennis A Senne; Jill Banks; Ian H Brown; Steve C Essen; Chang-Won Lee; Ruth J Manvell; Christian Mathieu-Benson; Valentina Moreno; Janice C Pedersen; Brundaban Panigrahy; Hernán Rojas; Erica Spackman; Dennis J Alexander Journal: Emerg Infect Dis Date: 2004-04 Impact factor: 6.883
Authors: Kathleen L MacMahon; Lisa J Delaney; Greg Kullman; John D Gibbins; John Decker; Max J Kiefer Journal: Public Health Rep Date: 2008 May-Jun Impact factor: 2.792
Authors: Peter H Goff; Florian Krammer; Rong Hai; Christopher W Seibert; Irina Margine; Adolfo García-Sastre; Peter Palese Journal: J Virol Date: 2013-05-22 Impact factor: 5.103
Authors: Andrea L Steege; Sherry Baron; Shelley Davis; Judith Torres-Kilgore; Marie Haring Sweeney Journal: Am J Public Health Date: 2009-10 Impact factor: 9.308
Authors: M Murti; D Skowronski; M Lem; C Fung; S Klar; M Bigham; S Loadman; C Chambers; J Pritchard; V Lee Journal: Can Commun Dis Rep Date: 2015-04-02
Authors: Arnt-Ove Hovden; Karl A Brokstad; Diane Major; John Wood; Lars R Haaheim; Rebecca J Cox Journal: Influenza Other Respir Viruses Date: 2009-01 Impact factor: 4.380
Authors: Joan L Robinson; Bonita E Lee; Jagdish Patel; Nathalie Bastien; Karen Grimsrud; Robert F Seal; Robin King; Frank Marshall; Yan Li Journal: Emerg Infect Dis Date: 2007-12 Impact factor: 6.883